These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 3955111)

  • 21. Tolerance to haloperidol-induced increases in dopamine metabolites: fact or artifact?
    Finlay JM; Jakubovic A; Fu DS; Fibiger HC
    Eur J Pharmacol; 1987 May; 137(1):117-21. PubMed ID: 3609130
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prefrontal cortex: possible site of antipsychotic action of haloperidol.
    Chang WH; Yeh EK; Hu WH; Tseng YT; Chung MC; Chang HF
    Biol Psychiatry; 1986 Apr; 21(4):422-4. PubMed ID: 3955118
    [No Abstract]   [Full Text] [Related]  

  • 23. Enhancement of haloperidol-induced increase in rat striatal or mesolimbic 3,4-dihydroxyphenylacetic acid and homovanillic acid by pretreatment with chronic methamphetamine.
    Toru M; Mataga N; Takashima M; Nishikawa T
    Psychopharmacology (Berl); 1981; 74(4):316-20. PubMed ID: 6794073
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evolution of plasma homovanillic acid (HVA) in chronic schizophrenic patients treated with haloperidol.
    Galinowski A; Poirier MF; Aymard N; Leyris A; Beauverie P; Bourdel MC; Loo H
    Acta Psychiatr Scand; 1998 Jun; 97(6):458-66. PubMed ID: 9669519
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 3,4-Dihydroxyphenylacetic acid and homovanillic acid in rat plasma: possible indicators of central dopaminergic activity.
    Bacopoulos NG; Hattox SE; Roth RH
    Eur J Pharmacol; 1979 Jun; 56(3):225-36. PubMed ID: 477719
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pretreatment plasma HVA and haloperidol response in acute mania.
    Chou JC; Czobor P; Tuma I; Charles O; Bebe R; Cooper TB; Chang WH; Lane HY; Stone DL
    J Affect Disord; 2000 Jul; 59(1):55-9. PubMed ID: 10814771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of single dose haloperidol administration on plasma homovanillic acid levels in normal subjects.
    Magliozzi JR; Doran AR; Gietzen DW; Olson AM; Maclin EL; Tuason VB
    Psychiatry Res; 1993 May; 47(2):141-9. PubMed ID: 8341767
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of effects of drugs on dopamine metabolism in the substantia nigra and the corpus striatum of rat brain.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):131-6. PubMed ID: 991922
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Correlation between neuroleptic-induced suppression of stereotyped behaviour and HVA concentrations in rat brain.
    Rollema H; Westerink BH; Grol CJ
    J Pharm Pharmacol; 1976 Apr; 28(4):321-3. PubMed ID: 6728
    [No Abstract]   [Full Text] [Related]  

  • 30. Homovanillic acid in caudate and pre-frontal cortex following acute and chronic neuroleptic administration.
    Bowers MB; Hoffman FJ
    Psychopharmacology (Berl); 1986; 88(1):63-5. PubMed ID: 2868484
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regulation of the synthesis and metabolism of striatal dopamine after disruption of nerve conduction in the medial forebrain bundle.
    Commissiong JW; Slimovitch C; Toffano G
    Br J Pharmacol; 1990 Apr; 99(4):741-9. PubMed ID: 2361171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apomorphine-haloperidol interactions: different types of antagonism in cortical and subcortical brain regions.
    Bacopoulos NG; Roth RH
    Brain Res; 1981 Feb; 205(2):313-9. PubMed ID: 7470869
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute and chronic effects of neuroleptics and acute effects of apomorphine and amphetamine on dopamine turnover in corpus striatum and substantia nigra of the rat brain.
    Nicolaou NM
    Eur J Pharmacol; 1980 Jun; 64(2-3):123-32. PubMed ID: 6105080
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma homovanillic acid in neuroleptic responsive and nonresponsive schizophrenics.
    Duncan E; Wolkin A; Angrist B; Sanfilipo M; Wieland S; Cooper TB; Rotrosen J
    Biol Psychiatry; 1993 Oct; 34(8):523-8. PubMed ID: 8274579
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regional homovanillic acid levels and oral movements in rats following chronic haloperidol treatment.
    Kolenik SA; Hoffman FJ; Bowers MB
    Psychopharmacology (Berl); 1989; 98(3):430-1. PubMed ID: 2501819
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Dopamine metabolites and catalepsy after lithium and haloperidol.
    Bowers MB; Rozitis A
    Eur J Pharmacol; 1982 Feb; 78(1):113-5. PubMed ID: 7200429
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of drugs on the formation of homovanillic acid in the rat retina.
    Westerink BH; Korf J
    Eur J Pharmacol; 1976 Nov; 40(1):175-8. PubMed ID: 11106
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment schedule as a determinant of the development of tolerance to haloperidol.
    Carey RJ; DeVeaugh-Geiss J
    Psychopharmacology (Berl); 1984; 82(3):164-7. PubMed ID: 6425895
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Repeated haloperidol administration changes basal release of striatal dopamine and subsequent response to haloperidol challenge.
    Zhang W; Tilson H; Stachowiak MK; Hong JS
    Brain Res; 1989 Apr; 484(1-2):389-92. PubMed ID: 2713698
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tolerance develops to the haloperidol-induced increase in the efflux of dopamine metabolites from the brains of unanesthetized, freely-moving rats.
    Nielsen JA; Duda NJ; Moore KE
    Life Sci; 1982 Oct; 31(14):1495-1500. PubMed ID: 6183554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.